Publications list for Dr Stephen Assinder

2013 | 2012 | 2011 | 2010 | 2009 | 2008

2013

   
  • Ghalayini, M., Dong, Q., Richardson, D., Assinder, S. (2013), Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells. Bioscience Reports. 33(3), e00042. [Abstract]
  • Wee, N., Weinstein, D., Fraser, S., Assinder, S. (2013), The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. International Journal of Biochemistry & Cell Biology. 45(5), 960-963. [Abstract]
  • Hua, S., Yao, M., Vignarajan, S., Witting, P., Hejazi, L., Gong, Z., Teng, Y., Niknami, M., Assinder, S., Richardson, D., Dong, Q. (2013), Cytosolic phospholipase A2alpha sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells. Biochimica et Biophysica Acta. 1831(6), 1146-1157. [Abstract]
  • Dixon, K., Lui, G., Kovacevic, Z., Zhang, D., Yao, M., Chen, Z., Dong, Q., Assinder, S., Richardson, D. (2013), Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. British Journal of Cancer. 108(2), 409-419. [Abstract]
  • Velonas, V., Woo, H., Remedios, C., Assinder, S. (2013), Current status of biomarkers for prostate cancer. International Journal of Molecular Sciences. 14(6), 11034-11060. [Abstract]
  • Sánchez-Pérez, A., Brown, G., Malik, R., Assinder, S., Cantlon, K., Gotsis, C., Dunbar, S., Fraser, S. (2013), Rapid detection of haemotropic mycoplasma infection of feline erythrocytes using a novel flow cytometric approach. Parasites & Vectors. 6, 158. [Abstract]

2012

   
  • Bower, N., Garcia de la Serrana, D., Cole, N., Hollway, G., Lee, H., Assinder, S., Johnston, I. (2012), STAC3 is required for myotube formation and myogenic differentiation in vertebrate skeletal muscle. Journal of Biological Chemistry. 287, 43936-43949. [Abstract]

2011

   
  • Assinder, S., Cole, N. (2011), Does TGF-β induced formation of actin stress fibres reinforce Smad dependent TGF-β signalling in the prostate?. Medical hypotheses. 76(6), 802-4. [Abstract]
  • Assinder, S. (2011), TAGLN (transgelin). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 15(6), 477-479.

2010

   
  • Assinder, S., Au, E., Dong, Q., Winnick, C. (2010), A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer. Molecular Carcinogenesis. 49(6), 525-531. [Abstract]
  • Tom, N., Assinder, S. (2010), Oxytocin in health and disease. The international journal of biochemistry & cell biology. 42(2), 202-5. [Abstract]
  • Prasad, P., Stanton, J., Assinder, S. (2010), Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer. Cell and tissue research. 339(2), 337-47. [Abstract]
  • Tom, N., Assinder, S. (2010), Oxytocin: Recent developments. Biomolecular Concepts. 1(5-6), 367-380.

2009

   
  • Assinder, S., Dong, Q., Mangs, H., Richardson, D. (2009), Pharmacological Targeting of the Integrated AKT, PTEN and TGF-{beta} Pathways in Prostate Cancer. Molecular Pharmacology. 75(3), 429-436. [Abstract]
  • Assinder, S., Stanton, J., Prasad, P. (2009), Transgelin: An actin-binding protein and tumour suppressor. The international journal of biochemistry & cell biology. 41(0), 482-6. [Abstract]
  • Assinder, S., Dong, Q., Kovacevic, Z., Richardson, D. (2009), The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochemical Journal. 417(2), 411-421. [Abstract]
  • Assinder, S. (2009), Oxytocin in the Pathophysiology of Prostate Cancer. In: Handbook of Oxytocin Research: Synthesis, Storage and Release, Actions and Drug Forms. (pp.155-170).United Kingdom: Nova Publishers.

2008

   
  • Assinder, S. (2008), Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells. The Prostate. 68, 115-21. [Abstract]
  • Nicholson, H., Assinder, S. (2008), Male gametogenesis. In: Textbook of Assisted Reproduction for Scientists in Reproductive Technology. (pp.3-30).Australia: VIVID Publishing.